Overview

Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes

Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine with the administration of amiloride, observe an enhanced natriuresis, reduction in blood pressure and weight compared to the administration of hydrochlorothiazide in Type 2 Diabetics.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of New Mexico
Collaborators:
Dialysis Clinic, Inc.
University of Pittsburgh
Treatments:
Amiloride
Hydrochlorothiazide